Advanced search

Patenting foundational technologies: Lessons from CRISPR and other core biotechnologies

Author
Organization
Abstract
In 2012, a new and promising gene manipulation technique, CRISPR-Cas9, was announced which seems likely to be a foundational technique in healthcare and agriculture. However, patents have been granted. As with other technological developments, there are concerns of social justice regarding inequalities in access. Given the technologies’ ‘foundational’ nature and societal impact, it is vital for such concerns to be translated into workable recommendations for policymakers and legislators. Colin Farrelly has proposed a moral justification for the use of patents to speed up the arrival of technology by encouraging innovation and investment. While sympathetic to his argument, this paper highlights a number of problems. By examining the role of patents in CRISPR and in two previous foundational technologies, we make some recommendations for realistic and workable guidelines for patenting and licensing.
Keywords
CRISPR-Cas9, Patents, Social justice, licensing, foundational technologies

Citation

Please use this url to cite or link to this publication:

Chicago
Feeney, Oliver, Julian Cockbain, Michael Morrison, Lisa Diependaele, Kristof Van Assche, and Sigrid Sterckx. 2018. “Patenting Foundational Technologies: Lessons from CRISPR and Other Core Biotechnologies.” The American Journal of Bioethics.
APA
Feeney, O., Cockbain, J., Morrison, M., Diependaele, L., Van Assche, K., & Sterckx, S. (2018). Patenting foundational technologies: Lessons from CRISPR and other core biotechnologies. The American Journal of Bioethics.
Vancouver
1.
Feeney O, Cockbain J, Morrison M, Diependaele L, Van Assche K, Sterckx S. Patenting foundational technologies: Lessons from CRISPR and other core biotechnologies. The American Journal of Bioethics. Taylor & Francis; 2018;
MLA
Feeney, Oliver, Julian Cockbain, Michael Morrison, et al. “Patenting Foundational Technologies: Lessons from CRISPR and Other Core Biotechnologies.” The American Journal of Bioethics (2018): n. pag. Print.
@article{8570724,
  abstract     = {In 2012, a new and promising gene manipulation technique, CRISPR-Cas9, was announced which seems likely to be a foundational technique in healthcare and agriculture. However, patents have been granted. As with other technological developments, there are concerns of social justice regarding inequalities in access. Given the technologies{\textquoteright} {\textquoteleft}foundational{\textquoteright} nature and societal impact, it is vital for such concerns to be translated into workable recommendations for policymakers and legislators. Colin Farrelly has proposed a moral justification for the use of patents to speed up the arrival of technology by encouraging innovation and investment. While sympathetic to his argument, this paper highlights a number of problems. By examining the role of patents in CRISPR and in two previous foundational technologies, we make some recommendations for realistic and workable guidelines for patenting and licensing. },
  author       = {Feeney, Oliver and Cockbain, Julian and Morrison, Michael and Diependaele, Lisa and Van Assche, Kristof and Sterckx, Sigrid},
  issn         = {1526-5161},
  journal      = {The American Journal of Bioethics},
  keyword      = {CRISPR-Cas9,Patents,Social justice,licensing,foundational technologies},
  language     = {eng},
  publisher    = {Taylor \& Francis},
  title        = {Patenting foundational technologies: Lessons from CRISPR and other core biotechnologies},
  year         = {2018},
}